Long term outcomes of Everolimus therapy in de novo liver transplantation: a systematic review and meta-analysis of randomized controlled trials
K. I. Bzeizi, S. Richard, A. AlBenmousa, D. Madhukar, A. A. Faisal, J. Rajiv, B. Dieter
This study evaluates the long-term outcomes of Everolimus therapy in liver transplant patients, finding improved renal function with non-inferior efficacy compared to standard calcineurin inhibitor therapy.
bioRxiv · Jul 15, 2019Immunology